Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Tunnicliffe

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Chest|March 8, 2017
The Right Ventricle in ARDSVasileios Zochios, Ken Parhar, William Tunnicliffe, et al.
Critical Care (London, England)|February 14, 2008
Kerbs von Lungren 6 antigen is a marker of alveolar inflammation but not of infection in patients with acute respiratory distress syndromeNazim Nathani, Gavin D Perkins, William Tunnicliffe, et al.
The New England Journal of Medicine|January 24, 2013
High-frequency oscillation for acute respiratory distress syndromeDuncan Young, Sarah E Lamb, Sanjoy Shah, et al.
Lancet (London, England)|December 15, 2011
Effect of intravenous β-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trialFang Gao Smith, Gavin D Perkins, Simon Gates, et al.
Health Technology Assessment (Winchester, England)|March 25, 2015
A randomised controlled trial and cost-effectiveness analysis of high-frequency oscillatory ventilation against conventional artificial ventilation for adults with acute respiratory distress syndrome. The OSCAR (OSCillation in ARDS) studyRanjit Lall, Patrick Hamilton, Duncan Young, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|May 29, 2008
Effect of social factors on winter hospital admission for respiratory disease: a case-control study of older people in the UKRachel E Jordan, Jeremy I Hawker, Jon G Ayres, et al.
Critical Care Explorations|March 27, 2025
Evaluation of Plasma Biomarkers to Understand the Biology and Heterogeneity of Treatment Effect in Lower Tidal Volume Ventilation Facilitated by Extracorporeal CO2 Removal in Acute Hypoxemic Respiratory Failure: A Secondary Analysis of the REST TrialAndrew J Boyle, Kiran Reddy, John Conlon, et al.
JAMA|August 31, 2021
Effect of Lower Tidal Volume Ventilation Facilitated by Extracorporeal Carbon Dioxide Removal vs Standard Care Ventilation on 90-Day Mortality in Patients With Acute Hypoxemic Respiratory Failure: The REST Randomized Clinical TrialJames J McNamee, Michael A Gillies, Nicholas A Barrett, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Chest|March 8, 2017
The Right Ventricle in ARDSVasileios Zochios, Ken Parhar, William Tunnicliffe, et al.
Critical Care (London, England)|February 14, 2008
Kerbs von Lungren 6 antigen is a marker of alveolar inflammation but not of infection in patients with acute respiratory distress syndromeNazim Nathani, Gavin D Perkins, William Tunnicliffe, et al.
The New England Journal of Medicine|January 24, 2013
High-frequency oscillation for acute respiratory distress syndromeDuncan Young, Sarah E Lamb, Sanjoy Shah, et al.
Lancet (London, England)|December 15, 2011
Effect of intravenous β-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trialFang Gao Smith, Gavin D Perkins, Simon Gates, et al.
Health Technology Assessment (Winchester, England)|March 25, 2015
A randomised controlled trial and cost-effectiveness analysis of high-frequency oscillatory ventilation against conventional artificial ventilation for adults with acute respiratory distress syndrome. The OSCAR (OSCillation in ARDS) studyRanjit Lall, Patrick Hamilton, Duncan Young, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|May 29, 2008
Effect of social factors on winter hospital admission for respiratory disease: a case-control study of older people in the UKRachel E Jordan, Jeremy I Hawker, Jon G Ayres, et al.
Critical Care Explorations|March 27, 2025
Evaluation of Plasma Biomarkers to Understand the Biology and Heterogeneity of Treatment Effect in Lower Tidal Volume Ventilation Facilitated by Extracorporeal CO2 Removal in Acute Hypoxemic Respiratory Failure: A Secondary Analysis of the REST TrialAndrew J Boyle, Kiran Reddy, John Conlon, et al.
JAMA|August 31, 2021
Effect of Lower Tidal Volume Ventilation Facilitated by Extracorporeal Carbon Dioxide Removal vs Standard Care Ventilation on 90-Day Mortality in Patients With Acute Hypoxemic Respiratory Failure: The REST Randomized Clinical TrialJames J McNamee, Michael A Gillies, Nicholas A Barrett, et al.
Pageof 1